Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 3Genitourinary 1Breast 1

Conditions

Breast Neoplasms 7Anemia 6Multiple Myeloma 2Lymphoma 2Small Cell Lung Carcinoma 1Red-Cell Aplasia, Pure 1Prostatic Neoplasms 1Precancerous Conditions 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Lung Neoplasms 1Leukemia 1Fatigue 1Esophageal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1

Interventions

Therapeutics 15Exercise 10Yoga 9Psychiatric Rehabilitation 8Mental Status and Dementia Tests 4Early Intervention, Educational 4Acupuncture Therapy 4Walking 3Surveys and Questionnaires 3Educational Status 3Control Groups 3Ultraviolet Therapy 2Transcranial Direct Current Stimulation 2Standard of Care 2Saline Solution 2Resistance Training 2Physical Therapy Modalities 2Music Therapy 2Methods 2Gene Expression Profiling 2Exercise Therapy 2Exercise Movement Techniques 2Enzyme-Linked Immunosorbent Assay 2Drug Therapy 2stinging nettle lectin 1reparixin 1peppermint oil 1methyl hydroxyethyl cellulose 1exemestane 1coenzyme Q10 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fatigue × Epoetin Alfa × Breast × Clear all
NCT00022386 2013-07-18

Epoetin Alfa in Treating Chemotherapy-Related Anemia in Women With Stage I, Stage II, or Stage III Breast Cancer

National Cancer Institute (NCI)

Phase 4 Completed
BreastClassical hematology

Anemia, Breast Neoplasms, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡